Fortress Biotech Inc

-0.15 (-5.03%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)267.77M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$39.23 Million
Adjusted EPS$0.12
See more estimates
10-Day MA$3.09
50-Day MA$3.23
200-Day MA$3.61
See more pivots

Fortress Biotech Inc Stock, NASDAQ:FBIO

2 Gansevoort Street, 9th floor, New York, New York 10014
United States of America
Phone: +1.781.652.4500
Number of Employees: 111


Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the following Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded on June 28, 2006 and is headquartered in New York, NY.